|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Noninterest-bearing | ||||||||||||||||||||
| Interest-bearing | ||||||||||||||||||||
| Total cash and cash equivalents | ||||||||||||||||||||
| Equity securities | ||||||||||||||||||||
| Available-for-sale securities (amortized cost basis of $26,266 and $25,825) | ||||||||||||||||||||
| Held-to-maturity securities (fair value of $3,968 and $4,451) | ||||||||||||||||||||
| Loans held-for-sale, net | ||||||||||||||||||||
| Finance receivables and loans, net | ||||||||||||||||||||
| Finance receivables and loans, net of unearned income | ||||||||||||||||||||
| Allowance for loan losses | ||||||||||||||||||||
| Total finance receivables and loans, net | ||||||||||||||||||||
| Investment in operating leases, net | ||||||||||||||||||||
| Premiums receivable and other insurance assets | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Assets of operations held-for-sale | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Deposit liabilities | ||||||||||||||||||||
| Noninterest-bearing | ||||||||||||||||||||
| Interest-bearing | ||||||||||||||||||||
| Total deposit liabilities | ||||||||||||||||||||
| Short-term borrowings | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Interest payable | ||||||||||||||||||||
| Unearned insurance premiums and service revenue | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| Liabilities of operations held-for-sale | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Equity | ||||||||||||||||||||
| Common stock and paid-in capital ($0.01 par value, shares authorized 1,100,000,000; issued 523,488,598 and 520,355,804; and outstanding 300,538,049 and 308,492,929) | ||||||||||||||||||||
| Preferred stock | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Treasury stock, at cost (222,950,549 and 211,862,875 shares) | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
Loading...